FOS and central nervous system cancer: In conclusion, we have developed a glioma-specific gene therapy system that expresses the HSV-tk suicide gene under direct transcriptional control of the FOS promoter, and have validated the therapeutic effects of this system in glioma in vitro and in vivo.